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PREFACE
The emergency room is one of the few settings in the health system of the United states,
where there is a lot of interaction between healthcare services and members of the society,
especially those that are socio-economically limited to accessing extensive health services.
These interactions makes the emergency room an ideal setting for collecting and analyzing
health-related data. Although there is a lot of parameters that can be feasibly studied and
analyzed, even with basic statistics, yet, several systems of collecting data are not
supplemented with suitable analyses. My primary motivation for this thesis is to contribute to
the effort of bridging the gap between the knowledge that is embedded in data that have not
been analyzed and the evidence basis for medical practice.
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Table 1: Demographic characteristics, hospital system, and primary diagnosis for patients’ first emergency department visit resulting in testing for syphilis, chlamydia/gonorrhea and HIV in four North
Texas counties (N=20,809)
Syphillis

P-Val

Not Tested

Tested

16,768 (80.6%)

4041 (19.4%)

Age

<0.001

HIV

P-Val

Not Tested

Tested

18,031 (86.7%)

2778 (13.3%)

0.0166

<0.001

Chlamydia/Gonorrhea

P-Val

Not Tested

Tested

12,131 (58.3%)

8,678 (41.7%)

0.074

0.0002

0-17

798 (4.8%)

159 (3.9%)

849 (4.7%)

108 (3.9%)

501 (4.1%)

456 (5.3%)

18-44

15928 (95%)

3867 (95.7%)

17,137 (95%)

2,658 (95.7%)

11,588 (95.5%)

8,207 (94.6%)

45-64

42 (0.25%)

14 (0.4%)

44 (0.2%)

12 (0.4%)

41 (0.3%)

15 (0.2%)

65+

0 (0.0%)

1 (<0.1%)

1 (<0.1%)

0 (0.0%)

1 (<0.1%)

0 (0.0%)

Gender

16768 (80.6%)

4041 (19.4%)

18,031 (86.7%)

4041 (19.4%)

12,131 (58.3%)

8,678 (41.7%)

1

1

<0.001

1

(female)
Race/Ethnicity
Non-Hispanic

<0.001

<0.001

<0.001

9091 (54.22%)

2674 (66.1%)

10,034 (55.7%)

1,731 (62.3%)

7,857 (64.8%)

3,908 (45%)

5132 (30.6%)

969 (24.0%)

5,398 (29.9%)

703 (25.3%)

2,750 (22.7%)

3,351 (38.6%)

2545 (15.2%)

398 (9.9%)

2,599 (14.1%)

344 (12.4%)

1,524 (14.1%)

1,419 (16.4%)

White
Non-Hispanic
Black
Other
Insurance
Private

<0.001
2611 (15.6%)

347 (8.59%)

<0.001
2,776 (15.4%)
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182 (6.6%)

<0.001
1,200 (9.9%)

1,758 (20.3%)

7281 (43.4%)

2283 (56.5%)

8,041 (44.6%)

1,523 (54.8%)

5,949 (49.0%)

3,615 (41.7%)

269 (1.6%)

38 (0.9%)

244 (1.4%)

63 (2.3%)

179 (1.5%)

128 (1.5%)

6607 (39.4%)

1373 (34.0%)

6,970 (38.7%)

1,010 (36.4%)

4,803 (39.6%)

3,177 (36.6%)

Medicaid/Medi
care
Other
Unknown
(Self-pay,
charity)
Patient’s

<0.001

<0.001

county of
residence
Dallas

10484 (62.5%)

3481 (86.1%)

11,749 (62.5%)

2,216 (86.1%)

9,668 (79.7%)

4,297 (49.5%)

Denton

1067 (6.4%)

121 (3.0%)

1,134 (6.3%)

54 (1.9%)

653 (5.4%)

535 (6.2%)

Tarrant

5217 (31%)

439 (10.9%)

5,148 (31%)

508 (18.3%)

1,810 (14.9%)

3,846 (44.3%)

Hospital county

<0.001

<0.001

<0.001

Dallas

9981 (59.5%)

3455 (85.50%)

11,232 (62.3%)

2,204 (79.3%)

9,579 (79.0%)

2,204 (79.3%)

Denton

1150 (6.8%)

96 (2.4%)

1,201(6.8%)

45 (1.6%)

618 (5.1%)

628 (7.2%)

Tarrant

5241 (31.3%)

442 (10.9%)

5,187 (28.8%)

496 (17.9%)

1,774 (14.6%)

3,909 (45.0%)

Collin

163 (1%)

27 (0.7%)

179 (1%)

11 (0.4%)

90 (0.7%)

100 (1.2%)

233 (1.4%)

21 (0.5%)

232 (1.3%)

22 (0.8%)

70 (0.6%)

184 (2.1%)

Other (Ellis,
Erath, Grayson,

iii

Hunt, Johnson,
Kaufman,
Rockwall, and
Wise)
Hospital system
County

<0.001

<0.001

<0.001

7746 (46.2%)

3426 (84.8%)

8674 (48.1%)

2498 (89.9%)

9586 (79.0%)

1586 (18.3%)

For Profit

1617 (9.65%)

254 (6.3%)

1825 (10.1%)

46 (1.7%)

1428 (76.3%)

443 (5.1%)

Faith Based

2337 (13.94%)

107 (2.7%)

2420 (13.4%)

24 (0.9%)

252 (2.1%)

2192 (25.3%)

5063 (0.5%)

253 (6.3%)

5106 (28.3%)

210 (7.6%)

864 (7.1%)

4452 (51.3%)

Safety Net

NFP
Not for
Profit
Primary

<0.001

<0.001

<0.001

diagnosis for
emergency
department
visit
Abortion

5313 (31.7%)

662(16.4%)

5,454 (30.3%)

521(18.8%)

2,773 22.9%)

3,202 (36.9%)

65 (0.4%)

249 (6.2%)

214 (1.2%)

100 (3.6%)

276 (2.3%)

38 (0.44%)

Cardiovascular

iv

CNS

20 (0.1%)

17 (0.4%)

26 (0.1%)

11 (0.4%)

25 (0.2%)

12 (0.1%)

GI

655 (3.9%)

134 (3.3%)

675 (3.8%)

114 (4.1%)

434 (3.6%)

355 (4.1%)

Heme

5 (0.03%)

4 (0.1%)

6 (0.0%)

3 (0.1%)

6 (0.1%)

3 ((<0.1%)

4 (0.02%)

6 (0.15%)

5 (0.03%)

5 (0.18%)

7 (0.06%)

3 (0.03%)

Syphi

2 (0.01%)

0 (0.00%)

2 (0.01%)

0 (0.00%)

2 (0.02%)

0 (0.00%)

lis

19 (0.11%)

0 (0.00%)

19 (0.11%)

0 (0.00%)

12 (0.10%)

7 (0.08%)

Chla

98 (0.58%)

6 (0.15%)

100 (0.55%)

4 (0.14%)

70 (0.58%)

34 (0.39%)

mydi

2829 (16.88%)

190 (4.71%)

2837 (15.74%)

182 (6.57%)

1319 (10.88%)

1700 (19.60%)

a

18 (0.11%)

0 (0%)

17 (0.09%)

1 (0.04%)

6 (0.05%)

12 (0.14%)

Gono

281 (1.68%)

37 (0.92%)

287 (1.59%)

318 (0.14%)

160 (1.32%)

158 (1.82%)

Infectious
Disease

rrhea
STI –
Other
s
GU/
UTI
Puerp
eral

v

Other
ID
Metabolic

160 (1.0%)

138 (3.4%)

182 (1.0%)

116 (4.2%)

255 (2.1%)

43 (0.5%)

Misc

35 (0.2%)

12 (0.3%)

38 (0.2%)

9 (0.3%)

29 (0.2%)

18 (0.2%)

6 (0.0%)

3 (0.1%)

7 (0.0%)

2 (0.1%)

7 (0.1%)

2 ((<0.1%)

7190 (42.9%)

2553 (63.3%)

8,098 (44.9%)

1,645 (59.4%)

6,670 (55.0%)

3,073 (35.4%)

Psychiatric

47 (0.3%)

20 (0.5%)

42 (0.2%)

25 (0.9%)

59 (0.5%)

8 (0.1%)

Renal

7 (0.04%)

2 (0.1%)

7 (0.0%)

2 (0.1%)

6 (0.1%)

3 ((<0.1%)

Respiratory

8 (0.1%)

0 (0.0%)

8 (0.1%)

0 (0.0%)

4 ((<0.1%)

0 (0.0%)

Musculoskeleta
l
Pregnancy
Complications
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BACKGROUND

Literature Review
Following an initial decrease in the incidence of congenital syphilis from 2008-2012,
the rate of congenital syphilis rose by 38% across the United States between 2012-2014 (2).
This trend followed a 22% rise in primary and secondary syphilis cases in women during the
same period.(1) Vertical transmission of syphilis is a significant public health concern,
contributing to stillbirth, infant mortality, and neurologic and skeletal morbidities in
survivors. (2) The Centers for Disease Control and Prevention (CDC) recommends that all
pregnant women be screened for sexually transmitted infections (STI) including HIV,
syphilis, and hepatitis B at the first prenatal visit regardless of prior testing. The American
College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task
Force (USPSTF) also support similar recommendations. Yet, a CDC investigation into this
epidemic revealed that 21% of women whose infants were diagnosed with congenital syphilis
had no prenatal care, and of those who had at least one prenatal visit, 43% received no
treatment for syphilis during pregnancy and 30% received inadequate treatment. (2, 3)
Little is understood about factors associated with low STI screening during pregnancy
in the US. In a 2014 study, Cha, et al. evaluated factors affecting the likelihood of STI
screening in pregnant women in Guam. They found that the biggest barrier to STI testing was
lack of prenatal care and insurance. Even women with access to prenatal care were not
routinely screened for syphilis before 24 weeks’ gestation. Despite a 93.5% overall rate of
screening for syphilis at any time during pregnancy, the authors found much lower screening
1

rates for other STIs, including 31% for HIV, 25.3% for chlamydia, and 25.7% for gonorrhea.
(8) This suggests potential disparity in testing practices based on risk perception by providers
or patients.
Public Health Significance
The emergency department (ED) presents public health opportunities to expand STI
and syphilis screening. ED screening can help expand services to underinsured women, and
represents a key point of entry into the health care system. (10) However, ED screening
practices for STIs depend on a variety of factors, including requirements for pre and post-test
counseling, ability to establish appropriate follow up, disagreement regarding appropriate
screening and diagnostic testing in an emergency setting, perception of disease prevalence,
and insurance coverage. (5, 10, 11) The annual National Hospital Ambulatory Medical Care
Survey in 2009 from all 50 states and the District of Columbia reviewed STI screening
practices in the emergency department and revealed that only 2.3% of patients who presented
with symptoms of STIs, sexual abuse, or pregnancy, received any HIV testing. The survey
also revealed that if ED staff perceived a low prevalence of HIV in their local population,
then testing was less likely to be offered, and some practitioners questioned if HIV screening
should even be performed in the emergency department where critical illnesses were a higher
priority. (10) Another study found that among women with no prenatal care, 44% had visited
emergency clinics and 33% of them were screened for syphilis, further demonstrating that the
ED provides another potential opportunity for testing. (9) Outside the ED setting, a review of
a U.S administrative claims database from 2009-2010 showed that 95% of pregnant patients
with Medicaid or commercial insurance were tested for syphilis and hepatitis B. Furthermore,
2

prenatal HIV screening rates were higher in younger women (15-19 years of age) and in the
southern United States. (6) This study suggests that testing for STIs varies between health
care settings, from primary care offices to emergency departments, and is influenced by
several factors including patient age and healthcare coverage. (11) Evaluating STI testing
patterns in EDs located in high-prevalence areas could potentially identify opportunities for
intervention.
Hypothesis, Research Question, Specific Aims or Objectives
Our aim was to examine population and individual-level factors associated with STI
testing patterns in a metropolitan area in the South through claims-based data from the
Dallas-Fort Worth Hospital Council.

METHODS
Data Collection
The Dallas-Fort worth Hospital Council Education and Research Foundation
(DFWHC) data warehouse is a repository of claims-based data from regional EDs in the
DFW area of north Texas. Since 2000, the DFWHC data warehouse has stored healthcare
data for approximately 10.7 million unique patients and 51 million hospital encounters. This
warehouse collects ED claims data from 80% of the hospitals in North Texas. The DFWHC
receives visit-centric data and establishes a regional enterprise master patient index (REMPI),
which assigns a unique ID to all patients, allowing researchers to track patients over time.
The data is submitted in a standardized format and processed through a data quality tool that
ensures accuracy and normalizes the data. The average data quality measurement for
3

participating facilities is 93%. Critical errors require correction before the patient encounter
can be entered into the database. One example of a critical error would be an encounter
missing the principal diagnosis code or having an invalid diagnosis code. The primary benefit
of using the DFWHC data is the large sample size of the database, which provided a robust
distribution for statistical analysis.
Study Setting
DFWHC data were extracted for all patients who visited an ED from July 2014
through June 2015 and who had at least one of three STI tests (HIV, syphilis or combined
GC/CT test) performed at the visit. Data were analyzed for EDs in Dallas, Tarrant, Collin,
and Denton counties, which include the two major population centers, Dallas and Fort Worth.
We limited this dataset to include women with a pregnancy-related diagnosis as defined by
ICD-9 codes 630-676 (Appendix), and excluded any diagnosis associated with a past medical
history of pregnancy or family history of pregnancy-related complications to limit inclusion
to active pregnancy cases. We only examined claims for sexually transmitted infections that
included HIV, syphilis or gonorrhea and chlamydia. Chlamydia (CT) and gonorrhea (GC)
tests were combined, as the most common test used is the combined nucleic acid
amplification test. HIV and syphilis screening was determined based on CPT codes.
Study Design
A cross-sectional study design. We reviewed the primary diagnoses (based on ICD-9
codes) and other factors including race, insurance coverage, and geographic location
(hospital county), to determine associations with STI testing. Primary diagnoses were
classified into the following categories: 1) early pregnancy loss or abortion-related, 2)
4

cardiovascular (including venous thrombosis and hypertension, 3) central nervous system
(including headaches and seizures), 4) gastrointestinal, 5) hematologic, 6) infectious diseases
(pertaining to genitourinary infections), 7) metabolic (related to glucose, thyroid, and bone
disorders), 8) musculoskeletal, 9) pregnancy complications (other than early pregnancy loss
or abortion-related), 10) psychiatric, 11) renal, 12) respiratory, and 13) miscellaneous.
Study Subjects
This study is considered a quality improvement study. Hence IRB approval was not
required to carry out this study. We evaluated claims-based data on 123,834 women who
visited north Texas emergency departments from 2014 to 2015 and were tested for a sexually
transmitted infection during the visit. Of these, a total of 20,809 women (16.8%) with a
pregnancy-related diagnosis were screened for HIV, syphilis, or gonorrhea and chlamydia.
These women had a total of 26,416 recorded visits.
Sample Size Calculation and/or Study Power
This is a retrospective study that is based on available data. No power computation
was performed.
Data Analysis
Statistical Analysis was performed using SAS 9.4 © to conduct descriptive and
inferential analyses on the data. We described the distribution of screening provided based on
race, age, insurance coverage, hospital, geographic location, and primary diagnosis. The
distributions and frequency were plotted using Tableau 2018.3.0© . We used the chi-square
test for univariate analyses of categorical variables to test for association. Also, we
performed a prevalence ratio estimation using the GENMOD procedure on SAS to model the
5

relationship between predictor variables: Hospital system, principal diagnosis, Hospital
county, patient county, Primary payer, patient race, and patient group and response variable:
Syphilis, HIV, Chalmydia and Gonorrhea testing patterns. For the models, Syphilis was used
as a reference group among the principal diagnosis category, for-profit-organizations were
used as the reference group for the hospital system category, Dallas was used as the reference
group for the hospital county category, Tarrant county was used as the reference group for
the patient’s county category, “Other’s insurance” which includes self-pay and commercial
insurances were used as the reference group for the insurance category, “Other race”, which
included Asian, and pacific American were used as the reference group for race, and the
patient age group 0-17 years were used as the reference group for the age category. A p value
of <0.05 was considered significant for all analyses.

Human Subjects, Animal Subjects, or Safety Considerations
This study was based on de-identified claims data. No human or animal subjects were
involved.
RESULTS
Testing Patterns for Syphilis
Of the total number of women meeting inclusion criteria, 19.4% were screened for
syphilis. In the subset of 4036 patients screened for syphilis, 1630 women were screened for
syphilis alone, 2,287 were screened for both syphilis and HIV, 32 were screened for syphilis,
chlamydia and gonorrhea, and 92 were screened for syphilis, chlamydia, gonorrhea and HIV.
Univariate analysis of factors associated with syphilis testing are shown in Table 1.
The County safety prevalence ratio was 0.7103 (0.5554 0.8652), faith based not for profit
6

was -0.5658 (-0.8051 -0.3265) and Not for profit was -1.0423 (-1.2272 -0.8573). Patient
county of residence was estimated at a prevalence ratio for Dallas 0.4316 (0.1694 0.6939),
and Denton 0.4811 (0.1123 0.8500). The other parameters did not show any significant
difference in the parameters for testing for syphilis.
Testing Patterns for HIV
Of the 20,809 women who presented to north Texas emergency departments with a
pregnancy-related diagnosis, 13.3% received screening tests for HIV. Univariate analysis of
factors associated with HIV testing are shown in Table 1. The significant prevalence ratio
were Abortion -1.2646 (-2.1486 -0.3806), and other STI -2.4227 (-3.7396 -1.1058). Faith
based NFP was not significant. County safety was (2.5908 2.2524 2.9291), and NFP 0.8141
(0.4736 1.1547).For insurance, Medicaid -0.4642 ( -0.7296 -0.1987), Private -0.6179 (0.9153 -0.3205) and unknown was -0.6936 (-0.9601 -0.4270). Patient race and patient age
group were not significant.
Testing Patterns for Chlamydia and Gonorrhea
Of the 20,809 women who presented to north Texas emergency departments with a
pregnancy-related diagnosis, 41.7% received screening tests for gonorrhea/chlamydia.
Univariate analysis of factors associated with GC/CT testing are shown in Table 1. There
was no significant prevalence ratio among the principal diagnosis group testing for
chlamydia and gonorrhea. There was a prevalence ratio of -0.319 (-0.5032, -0.2789) for
county safety net testing for chlamydia and gonorrhea. There was prevalence ratio of 0.9972
(0.8866 - 1.1077) for Faith based NFP, and a prevalence ratio of 1.4182 (1.3155,
1.5208) for Not for profit hospital systems. Collin 0.2924 (0.0862, 0.4985), Denton 0.1749
7

(0.0478 0.3019), Others 0.7652 (0.6115 0.9188) Tarrant0.6951 (0.5743 0.8158). There were
no significant difference in prevalence ratio among the patient county, primary insurance or
patient age group. For patient race, black was -0.1623 (-0.2280 -0.0967) and non-Hispanic
white was -0.3758 (-0.4385 -0.3130).

Discussion
After reviewing visit data for 20,809 women with a pregnancy-related diagnosis who
accumulated 26,416 visits to north Texas emergency departments over a 12-month period
and were screened for at least one STI, we determined three main findings. First, women
with a pregnancy-related diagnosis who presented with a cardiovascular, metabolic, or CNSrelated complaint were more likely to be screened for syphilis compared to women who
presented with symptoms of an infectious disease or potential abortion. The cardiovascular
and CNS symptoms may implicate tertiary or neuro-syphilis as a risk factor and thus may
have prompted testing, but metabolic symptoms are typically less associated with syphilis. In
comparison, presentation with genitourinary infectious complaints and abortion can be
indications of primary or secondary syphilis in the mother or congenital syphilis that can
result in abortions. This paradoxical relationship with testing patterns and patient
presentation warrants further exploration through in-depth chart reviews to determine what
prompted providers to test for the same. It is also intriguing that pregnant women who
presented with infectious complaints were more likely to receive GC/CT than HIV testing,
considering that immunosuppression and consequent risk for infections is more linked with
HIV than GC/CT.
8

Second, patient factors such as race and age appeared to affect rates of STI testing
across north Texas emergency departments. White women were more likely to be screened
for syphilis or HIV, which is in contrast to black women who were more likely to be
screened for chlamydia and gonorrhea. Women less than 17 years were more likely to be
screened for chlamydia and gonorrhea, compared to women aged 18-44 years who were
more likely to be tested for syphilis, and women 45-64 years were more likely to be tested for
HIV. These patterns may have been influenced by some epidemiologic profiles and
guidelines that focus on gonorrhea/chlamydia testing in women under the age of 25. (4) In a
review of Medicaid claims data looking at women 15-21 years of age and chlamydia
screening rates, this showed that black women were screened more frequently, which is in
concordance with our results. (12)
Recommendations from the CDC, ACOG, and USPSTF are published to guide
testing during pregnancy in order to reduce preventable causes of morbidity and mortality
related to sexually transmitted infections to both the mother and child before and after birth.
(2) Of these 20,809 women who were presumably considered at risk for an STI based on the
fact that they were tested for either HIV, syphilis or GC/CT, 4,041 women received a sole
syphilis test and 2,287 women received both syphilis and HIV testing at the same visit,
compared to only 122 women who received syphilis and GC/CT testing and 90 women who
had syphilis, GC/CT, and HIV testing. A retrospective review of pregnant women in an
urban hospital revealed several factors that were missed opportunities for screening that
resulted in congenital syphilis, one of which was women not being screened at the
recommended trimester. (9) A study of HIV-infected pregnant women who underwent STI
9

screening, found lower rates of HIV transmission from mother-to-child in women without
gonorrhea or chlamydia compared to HIV-infected pregnant women with one or both
gonorrhea or chlamydia. Untreated infections not only have maternal complications, but can
lead to preterm labor, conjunctivitis, disseminated disease, and even fetal loss. (5)
A 2015 CDC review of STI surveillance in both men and women in the United States
revealed that the South (including Texas) had the highest number of cases of syphilis,
chlamydia, and gonorrhea. (4) When further broken down in the north Texas area, Dallas
county had higher rates of gonorrhea, chlamydia, and syphilis than Tarrant and Collin
counties in 2015. (4) Although there were many missed opportunities as evidenced by the
low rate of STI screening in pregnant women, this review allows us to evaluate specific data
points as potential areas of improvement in STI testing patterns in the ED. In our dataset,
hospitals in Dallas County had higher screening rates for syphilis and HIV, compared to
hospitals in the neighboring Tarrant County (which serves the city of Fort Worth) who had
higher rates of testing for chlamydia and gonorrhea. Such a trend may be explained by
different practice cultures in individual health settings and may warrant further exploration
through interaction with practice providers in both settings.
There are some limitations to our approach. One limitation of this ED claims-based
data analysis is the absence of specific diagnostic test results and treatment details outside of
the ED setting, including from prenatal clinics. Laboratory testing results from ambulatory
visits could be captured through in-depth electronic medical record (EMR) chart reviews.
However, since the highest testing rates took place at county-funded safety net settings and
utilization of routine health care is generally low for pregnant women who seek care at safety
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net settings, we can capture healthcare utilization across a comprehensive geographic setting
which is more challenging to do with individual hospital-based EMRs. While this data type
cannot provide detailed information on the types of presenting symptoms outside of the
codes used for claims, it does provide a population-level snapshot of patterns of care.
Further study is needed to explore the specific trends that have emerged through provider
surveys and in-depth chart reviews to identify potential causal associations driving these
unique STI testing patterns in EDs.
CONCLUSION
The proportion of women screened for syphilis alone or in combination with other STIs was
low among those with a pregnancy-related diagnosis who presented to emergency
departments in the DFW region. Patient factors including race, age, and presenting
symptoms, and hospital factors such as geographic location were associated with differences
in STI screening patterns.
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